-
2023-503974-19-00
10
Osteoarthritis in knee joint
-
2023-509988-24-00
11
Hip and knee osteoarthritis
-
2024-518016-39-00
10
Respiratory tract diseases
-
2025-522855-25-00
5
Urinary Bladder Neoplasms
-
2025-524386-24-00
5
2026-06-25
Head and neck cancer
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2023-504231-41-01
4
2024-10-02
Locally advanced or metastatic urothelial cancer
-
2023-504918-29-00
5
2024-08-22
Hormone receptor positive breast cancer
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2024-517457-27-00
5
2025-06-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-511652-40-00
5
2025-02-05
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-503442-30-00
5
2022-10-14
Multiple Myeloma
-
2023-510527-29-00
4
2020-09-01
Cancer
-
2024-510719-31-00
5
2025-01-24
Moderate to Severe Vasomotor Symptoms (VMS)
-
2022-501343-33-00
5
2023-10-18
Biochemically recurrent prostate cancer
-
2023-505552-22-00
5
2023-02-24
Stage I-III Triple-negative Breast Cancer with residual invasive disea
-
2024-515404-39-00
5
2021-01-14
Breast cancer
-
2023-506911-16-00
5
2020-12-04
ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTAT
-
2023-506365-64-00
5
2020-10-16
Deleterious Germline or Somatic Homologous Recombination Repair (HRR)
-
2022-501102-35-00
5
2019-12-02
Early triple negative breast cancer
-
2023-506614-40-00
6
2019-11-11
Severe eosinophilic asthma
-
2024-516178-31-00
5
2016-08-24
Head and neck squamous cell carcinoma (HNSCC)
-
2023-505543-39-00
5
2024-02-12
Chronic Obstructive Pulmonary Disease (COPD)